SEDRAH SELECTIONS PARSHAS BO 5772 BS”D Ch. 7, v. 17: “Hi’nei onochi ma’keh” – Behold I will smite – Many commentators explain the appropriateness of smiting the Egyptians with specifically the ten plagues, as recorded in our and the following parshios. The Kli Yokor offers: 1) The Nile was smitten in response to Paroh’s saying that the Nile was his and he created himself (
Advantag of ingestion administration way is its easiness even when applied at home. But with their help necessary treatment concentration in blood cannot be always quickly achieve amoxil online transaction is carried out on anonymity and mutual profit principles, and in addition customers will be positively surprised with quality and speed of service.
Optipharm.co.zaTREATMENT NAÏVE / NEW
(B) PRESCRIBING DOCTOR ASSESSMENT
PRINCIPLE MEMBER INFORMATION
Principal Member’s Initials
Principle Member’s First Name
Principal Member’s Surname
Medical Aid Number
Patient Identity Number
- - - Dependant Code
Contact Telephone Number
Allergies – Please tick the following if applicable:
Please specify other:
Is the treatment required as a prophylaxis - post exposure
Has the patient had:
Elevated Uric Acid Level
CD 4 COUNT ___________________________ mm
VIRAL LOAD __________________________________ RNA Copies/ml
STD Screen __________________________________________________________________________________________________________________
TB Contacts YES / NO
WHO Staging _________________________________________________
TB Treatment, define: _________________________________________________________________________________________________________
Is patient pregnant? YES / NO
Date of last test: ______________________________________________________________________________________________________________
Is there any significant cervical and/or auxilliary lymphao anopathy?
Is there any abnormal finds on examination of skin?
If YES, please define: ______________________________________________________________________
Is oral candidissis present?
Is there evidence of recent memory loss or development delays (children)?
Are there any other findings on examination?
If YES, Please define: ______________________________________________________________________
PLEASE NOTE THAT THE EXAMINATION DETAILS ARE ESSENTIAL FOR REGISTRATION & AUTHORIZATION – KINDLY PROVIDE COPIES OF
PATHOLOGY REPORTS IF AVAILABLE.
NAME, STRENGTH & DOSAGE OF MEDICATION CURRENTLY PRESCRIBED
DURATION OF TREATMENT REASON
B = SIDE EFFECTS
Other Medication used on a regular basis: ____________________________________________________________________________________
Has member been hospitalized during the last 12 months YES / NO Date: ______________________________________________________
BHF PRACTICE NUMBER:
HPC REG NUMBER:
PRACTICE POSTAL ADDRESS:
DOCTORS SIGNATURE: ______________________________________________________ DATE: ___________________________________________
CONDITIONS, UNDERTAKINGS & WARRANTIES
All member/patient information disclosed by means of this application will be treated as confidential and wil not be revealed in
any form to any party other than the direct employees of Optipharm and the patients Medical Scheme, unless specific written
authorization/consent has been given to Optipharm by the patient.
CUSTOMER CARE CALL CENTRE: 0 8 6 0 9 0 6 0 9 0
FAX NUMBER: 0 1 1 – 6 7 9 – 5 7 8 5
TELEPHONE NUMBER: 0 1 1 – 6 7 9 – 5 7 8 4
E-MAIL - GENERAL INQUIRIES/ MEDICINE RE-ORDERS
CLINICAL INQUIRIES: - WEBSITE:
MAY 15, 2005 A l l t h e C l i n i c a l N e w s i n S i g h t Punctal plugs plus topical agent maximize dry eye relief Combination offers improvement with less reliance on artificial tears By Cheryl Guttman scores in the three groups ranged from 2 to 2.3 at Dual approach baseline (possible score range, 0 to 4). All groups“Management of dry eye has received increased at-show